ReviewJournal of biomaterials applications2026
Challenges and prospects of polymeric biomaterials in immune engineering: A review.
Review in Journal of biomaterials applications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From Therapeutic Dilemma to Precision Modulation: Harnessing Biomaterials to Target the Dual Face of TGF-β in Osteoarthritis.Journal of inflammation research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Immune engineering is a vast and rapidly developing field with a strong focus on polymeric materials. The importance of these biomaterials in immune engineering revolves around their ability to provide bioactive molecules to the target site, which influences the immune system. Their functional performance depends on various structural and functional properties of the biomaterial, which are also influenced by the host immune microenvironment. This work focuses on the current state of the art, the attributes of polymer-based biomaterials, and their limitations in immune engineering applications. This review not only elaborates on the advantages of polymeric biomaterials in immune engineering but also critically analyses the potential of these biomaterials in this field. The current work begins with the identification of key characteristics of polymer-based biomaterials for immune engineering, then explores different aspects of various polymeric materials and their importance in immune engineering applications. One of the key advantages of polymeric materials is that they can be efficiently designed to deliver bioactive molecules that significantly influence the host immune system. On the other hand, a notable limitation of these materials involves the development of adverse immune responses that can often occur due to the incompatibility of polymeric biomaterials with the host immune system. Finally, the review delves into the future perspectives and potential of these materials in immune engineering based personalized medicine and/or engineering living material (ELM) specific applications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.